BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11021819)

  • 1. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.
    Ye H; Dogan A; Karran L; Willis TG; Chen L; Wlodarska I; Dyer MJ; Isaacson PG; Du MQ
    Am J Pathol; 2000 Oct; 157(4):1147-54. PubMed ID: 11021819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
    Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
    J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
    Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
    J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.
    Liu H; Ye H; Dogan A; Ranaldi R; Hamoudi RA; Bearzi I; Isaacson PG; Du MQ
    Blood; 2001 Aug; 98(4):1182-7. PubMed ID: 11493468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
    Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
    Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
    Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
    Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of caspase-8 activity caused by overexpression of BCL10 contributes to the pathogenesis of high-grade MALT lymphoma.
    Chen Y; Yang Y; Sun M; Yan Z; Wu L; Cui X; Zhang G; Morris SW; Zhang Q
    Pediatr Blood Cancer; 2012 Jun; 58(6):865-71. PubMed ID: 21954216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL10 expression and localization in ocular adnexa MALT lymphomas: a comparative cytogenetic and immunohistochemical study.
    Cerrone M; Collina F; De Chiara A; Corazzelli G; Curcio MP; De Renzo A; Russo F; Cantile M; Staibano S; Strianese D; Tranfa F; Botti G; De Rosa G; Franco R
    Histol Histopathol; 2014 Jan; 29(1):77-87. PubMed ID: 23846624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
    Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases.
    Liguori G; Cantile M; Cerrone M; La Mantia E; Di Bonito M; Zanconati F; Curcio MP; Aquino G; La Mura A; Giannatiempo R; De Chiara A; Lombardi A; Botti G; D'Antonio A; Caraglia M; Franco R
    Oncol Rep; 2012 Oct; 28(4):1211-6. PubMed ID: 22842723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.
    Maes B; Demunter A; Peeters B; De Wolf-Peeters C
    Blood; 2002 Feb; 99(4):1398-404. PubMed ID: 11830492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.
    Sagaert X; Laurent M; Baens M; Wlodarska I; De Wolf-Peeters C
    Mod Pathol; 2006 Feb; 19(2):225-32. PubMed ID: 16341151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.
    Gallardo F; Bellosillo B; Espinet B; Pujol RM; Estrach T; Servitje O; Romagosa V; Barranco C; Boluda S; García M; Solé F; Ariza A; Serrano S
    Hum Pathol; 2006 Jul; 37(7):867-73. PubMed ID: 16784987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.
    Banerjee SK; Weston AP; Zoubine MN; Campbell DR; Cherian R
    Am J Pathol; 2000 Jan; 156(1):217-25. PubMed ID: 10623670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL10 gene mutation in lymphoma.
    Du MQ; Peng H; Liu H; Hamoudi RA; Diss TC; Willis TG; Ye H; Dogan A; Wotherspoon AC; Dyer MJ; Isaacson PG
    Blood; 2000 Jun; 95(12):3885-90. PubMed ID: 10845924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
    Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
    Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
    Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.